기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
원발성 비강 림프종의 CT및 MR영상 : 초기 진단 및 추적 검사 시 유용성
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 원발성 비강 림프종의 CT및 MR영상 : 초기 진단 및 추적 검사 시 유용성
저자명
김응엽
간행물명
대한방사선의학회지
권/호정보
1998년|39권 5호|pp.857-862 (6 pages)
발행정보
대한영상의학회
파일정보
정기간행물|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

Purpose : To describe CT and MR findings of Primary nasal NK/T-cell lymphoma and to evaluate the usefulness of CT and MR imaging for initial diagnosis and during follow-up. Materials and Methods : Thirteen patients with biopsy-proven primary nasal NK/T-cell lymphoma (M:8, F:5;age 30-78, mean:47.3 years) were included in this study. CT scans were obtained in seven patients and MR images in ten, and both CT and MR images in four. During follow-up, CT images were obtained in four patients, MR images in eight, and both types of image in two. Signal intensity or attenuation, location, and shape of the tumor were assessed on CT and MR images, which were also compared in terms of evaluation of the extent of the tumor and the assessment of residual tumor during follow-up.Results : Enhanced CT scans showed slightly lower(6/7) or iso-attenuation (1/7) or the tumor than of the wall of the nasal cavity. In all cases, the tumor was of slightly lower signal intensity on T2WI and gadolinium-enhancedT1WI than nasal cavity mucosa. Infiltrative wall thickening of the nasal cavity (13/13) and a polypoid mass (5/13) were demonstrated on CT and MR images. The tumor margin was partially indistinct (6/7) or distinct (1/7) on initial CT, but distinctly identified on initial MR images in all cases. During follow-up, MR was superior to CT for the assessment of residual tumor in two patients. Conclusion : Infiltrative wall thickening of the nasal cavity may be a characteristic feature of primary nasal NK/T-cell lymphoma, and MR images were superior to CT for the assessment of tumor extent and for the diagnosis of residual tumor during follow-up.